TPG Group Holdings (SBS) Advisors’s Albireo Pharma Inc ALBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-486,181
Closed -$12.4M 44
2019
Q4
$12.4M Sell
486,181
-230,200
-32% -$4.6M 0.18% 36
2019
Q3
$14.3M Hold
716,381
0.21% 40
2019
Q2
$23.1M Hold
716,381
0.35% 33
2019
Q1
$23.1M Hold
716,381
0.45% 34
2018
Q4
$17.6M Hold
716,381
0.28% 38
2018
Q3
$23.6M Hold
716,381
0.3% 40
2018
Q2
$25.4M Sell
716,381
-60,715
-8% -$1.97M 0.33% 37
2018
Q1
$25.3M Hold
777,096
0.38% 30
2017
Q4
$19.9M Hold
777,096
0.31% 33
2017
Q3
$16.3M Hold
777,096
0.26% 34
2017
Q2
$16M Hold
777,096
0.22% 36
2017
Q1
$18.6M Hold
777,096
0.23% 41
2016
Q4
$13.8M Buy
+777,096
New +$16.1M 0.15% 43

Other funds holding ALBO

TPG Group Holdings (SBS) Advisors's ALBO Position: Q1 2020 in Review

TPG Group Holdings (SBS) Advisors sold out of Albireo Pharma Inc (ALBO) in Q1 2020, closing a stake of 486,181 shares — an estimated $12.4M sold.

TPG Group Holdings (SBS) Advisors first reported a position in ALBO in Q4 2016 and held it in 13 quarters. The position peaked at $25.4M in Q2 2018. 69 funds tracked by Wall St. Rank hold ALBO as of Q1 2020.

  • TPG Group Holdings (SBS) Advisors reported no remaining Albireo Pharma Inc position as of Q1 2020 after selling out during the quarter.
  • TPG Group Holdings (SBS) Advisors sold 486,181 Albireo Pharma Inc shares in Q1 2020, an estimated $12.4M.
  • TPG Group Holdings (SBS) Advisors first reported a position in Albireo Pharma Inc in Q4 2016 and held it in 13 quarters.
  • TPG Group Holdings (SBS) Advisors's Albireo Pharma Inc position peaked at $25.4M in Q2 2018.
  • 69 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2020.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q1 2020, filed 15 May 2020.